GENERAL, O. Reg. 201/96
Section 19
Cite as GENERAL, O. Reg. 201/96, s. 19 · current to November 11, 2026 · consolidated from July 1, 2026 · read from e-Laws on November 16, 2026
The text
(1) For the purposes of subsections 4 (6) and 6 (5) of the Act, the executive officer shall not pay the amount determined under subsection 4 (5) of the Act in respect of a prescription that contains a direction that there be no substitutions unless the following conditions are met:
1. In the case of a written prescription, the direction is made by the prescriber writing “no sub” or “no substitutions” on the prescription.
2. The eligible person for whom the listed drug product is supplied has previously been administered and experienced an adverse reaction to,
i. another drug product that is interchangeable with the drug product supplied, in the case where only one product has been designated as interchangeable with the drug product supplied and is generally available for sale in Ontario, or
ii. two drug products that are interchangeable with the drug product supplied, in the case where two or more products have been designated as interchangeable with the drug product supplied and are generally available for sale in Ontario.
3. The adverse reaction described in paragraph 2 is documented for each applicable interchangeable product as follows:
i. In the case of a written prescription, the prescription is accompanied by an adverse drug reaction reporting form completed and signed by the prescriber in which the interchangeable product that caused the adverse reaction is identified.
ii. In the case of a verbal prescription, the prescriber satisfies the operator of the pharmacy or the dispensing physician that an adverse drug reaction reporting form in which the interchangeable product that caused the adverse reaction is identified has been completed and signed by the prescriber and will be delivered to the operator of the pharmacy or the dispensing physician forthwith. O. Reg. 284/15, s. 4.
(2) In paragraph 3 of subsection (1),
“adverse drug reaction reporting form” means the Health Canada adverse drug reaction reporting form available from Health Canada or from the Ministry. O. Reg. 284/15, s. 4.
(3) This section, as it existed immediately before October 1, 2015, continues to apply to prescriptions authorized by a prescriber before that day, including any renewals or extensions of those prescriptions that take the form of new prescriptions. O. Reg. 284/15, s. 4.
Read the GENERAL on e-Laws ↗
Made under Ontario Drug Benefit Act, R.S.O. 1990, c. O.10.